Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Date:12/20/2010

drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any license or collaboration agreement, including Regeneron's agreements with Astellas, the sanofi-aventis Group and Bayer HealthCare, to be canceled or terminated without any product success, and risks associated with third party intellectual property.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quarter ended September 30, 2010. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.

Bayer Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management.  Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.  These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com.  The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Your Contact at Bayer:Doreen Schroeder, Tel. +49 30 468-11399E-Mail: doreen.schroeder@bayer.com Your Investor Relations Contact at Regeneron:Michael Aberman, M.D. Tel. +1 (914) 345-7799E-Mail: michael.aberma
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Endo International plc (NASDAQ: ... announced today that it has commenced an underwritten public ... All ordinary shares in the offering are to be ... also grant to the underwriters of the Offering an ... the date of the final prospectus supplement, to purchase ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
(Date:6/2/2015)... 2, 2015   PDI , a leader ... a series of corporate commitments designed to educate ... the threat of antimicrobial-resistant microorganisms as part of ... Disease Control and Prevention (CDC) and in support ... Antibiotic-Resistant Bacteria. Along with other key ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2
... TORONTO, Nov. 8, 2010 Millennium Research Group ... intelligence, has released its latest surgical navigation systems ... geographies. These two reports cover the breakdown of ... used in neurosurgery, spine, ENT, orthopedic, and soft ...
... SALT LAKE CITY, Nov. 8, 2010 TechniScan, Inc. ... device company engaged in the development and commercialization of an ... its convertible debt. TechniScan entered into amendments with ... extend the maturity date of its entire portfolio of secured ...
Cached Medicine Technology:Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group 2TechniScan, Inc. Announces Restructuring of Convertible Debt 2
(Date:6/3/2015)... evigilo, a world leader in delivering ... new branding by launching a new and enhanced content-centric ... identity: the logo depicting a sun-like image with a ... – To Know. To Act. In time. The color ... A global, borderless approach to alerting and delivering safety ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Allred Dental, a ... coupon for the months June-September, 2015 along with a $100 ... for limited time only. , “Sometimes wisdom teeth can be ... or jawbone. They can also only partially break through the ... and recovery is easier in young people, as they do ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... "100K Factory" system was released to public yesterday, ... around the Internet. HonestyFirstReviews.com's senior product reviewer Tiffany ... posting a detailed review of the course on ... of training courses available for Internet marketers looking ...
(Date:6/2/2015)... June 02, 2015 MEDIA ADVISORY, ... 571-319-9594 (cell) , Email: ewallace(at)mentalhealthamerica(dot)net , Breaking News: ... Mental Health Legislation at MHA Annual Conference Thursday ... Rep. Murphy to address the Mental Health America ... long-awaited updated version of the Helping Families in ...
Breaking Medicine News(10 mins):Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2
... the use of the nucleoside polymerase inhibitor, R1626, to ... in the August issue of Hepatology , a ... of the American Association for the Study of Liver ... Interscience ( www.interscience.wiley.com ). , The first study ...
... world, scientists are attempting to recognize and treat schizophrenic ... this will improve the prognosis, which has often been ... International ( Dtsch Arztebl Int 2008; 105[30]: ... Psychotherapy at Cologne University describes the current state of ...
... Prevention Plan to Employers, DALLAS, July ... the leader in disease prevention,and Physicians Planning ... a,strategic alliance that will give PPG employee ... Medicine,s groundbreaking prevention program to,employers. Physicians Planning ...
... helps protect Verispan,s HIPAA-compliant, de-identified, patient-centric market research data used ... ... Reston, VA and Ottawa, ON (PRWEB) July 31, 2008 ... specializing in host intrusion defense, today announced that http://www.verispan.com/ ...
... ... PITTSBURGH, July 31 The Management Board of Bayer AG,announced ... Bayer,Corporation and the Senior Bayer Representative in North America,succeeding Dr. ... of service, effective October 1, 2008. Bayer Corporation is the ...
... In Recognition of World,Breastfeeding Week, Mary ... free online access to Breastfeeding Medicine, (http://www.liebertpub.com/bfm ... Breastfeeding,Medicine, a MEDLINE journal, the official publication ... international peer-reviewed medical journal,providing physicians with the ...
Cached Medicine News:Health News:New treatment therapy helps inhibit hepatitis C 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 3Health News:Verispan Calls on Third Brigade for Added Data Protection 2Health News:Verispan Calls on Third Brigade for Added Data Protection 3Health News:Photos: Bayer Names New U.S. CEO 2Health News:Photos: Bayer Names New U.S. CEO 3Health News:Photos: Bayer Names New U.S. CEO 4Health News:Mary Ann Liebert, Inc. Provides Complimentary Online Access to Breastfeeding Medicine for the Month of August 2
QIAvac 6S provides all manifold components for processing QIAGEN 8-well strips....
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 384-well format...
Medicine Products: